Odnatron (Ondansetron Hydrochloride)

Ondansetron Hydrochloride, the active ingredient in Odnatron, is a 5-HT3 receptor antagonist presented as a tablet for oral use. It treats and prevents nausea and vomiting associated with chemotherapy, radiation therapy, and surgery in adult and pediatric patients. GNH USA supplies Odnatron as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

GNH USA supplies Odnatron as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

Odnatron is a 5‑HT3 receptor antagonist used in the management of nausea and vomiting pathways.

- Chemotherapy‑induced nausea and vomiting: helps prevent and control acute and delayed episodes. - Radiation‑induced nausea and vomiting: reduces the frequency and severity of symptoms. - Post‑operative nausea and vomiting: decreases incidence after surgical procedures. - Pregnancy‑related hyperemesis gravidarum: used when benefits outweigh risks, under specialist supervision. - Anticipatory nausea: lessens nausea that develops before chemotherapy sessions.

Side effects of Ondophyll (Ondansetron Hydrochloride) are generally mild and reversible.

Common Side Effects: - Headache - Constipation - Diarrhea - Fatigue - Dizziness - Injection site pain (if administered parenterally)

Serious or Rare Side Effects: - Prolonged QT interval leading to cardiac arrhythmias - Severe allergic reactions such as anaphylaxis - Serotonin syndrome when combined with other serotonergic agents - Hepatic enzyme abnormalities - Severe skin reactions (e.g., Stevens‑Johnson syndrome) - Vision changes or blurred vision

When prescribing Odnantrn ​      ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​   ​    g   g   t   g  t  

-   t  \

The           g   ext{  t  ewline  """"  " ""  """ " "  " " "" " """ " " """ " """ """""""""""""""""""""""""""""""""""""""""""""""